Time for Geriatric Assessments in Cancer Care: William Dale, Mazie Tsang, and John Simmons
GeriPal
SEPTEMBER 7, 2023
So I would say that a lot of the education we received were on cutting edge research and the latest drugs in clinical trials, the latest cellular therapies that are coming out. There’s really no added extra resource or time that the coordinators really need to put to doing the screening, themselves. And there are only two of us.”
129 
Let's personalize your content